We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Curious about Corteva, Inc. (CTVA) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Read MoreHide Full Article
The upcoming report from Corteva, Inc. (CTVA - Free Report) is expected to reveal quarterly earnings of $0.21 per share, indicating a decline of 34.4% compared to the year-ago period. Analysts forecast revenues of $4.23 billion, representing an increase of 6.3% year over year.
Over the last 30 days, there has been a downward revision of 3.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some Corteva, Inc. metrics that are commonly tracked and projected by analysts on Wall Street.
Based on the collective assessment of analysts, 'Revenue- Crop Protection' should arrive at $2.42 billion. The estimate indicates a change of +9.8% from the prior-year quarter.
Analysts forecast 'Revenue- Seed' to reach $1.82 billion. The estimate indicates a year-over-year change of +2.6%.
The collective assessment of analysts points to an estimated 'Revenue- Seed- Other oilseeds' of $89.86 million. The estimate indicates a year-over-year change of +3.3%.
Analysts' assessment points toward 'Revenue- Crop Protection- Herbicides' reaching $1.14 billion. The estimate indicates a year-over-year change of +10.9%.
Analysts predict that the 'Revenue- Crop Protection- Insecticides' will reach $557.11 million. The estimate indicates a year-over-year change of +13.7%.
The average prediction of analysts places 'Revenue- Crop Protection- Fungicides' at $357.43 million. The estimate suggests a change of +11.7% year over year.
According to the collective judgment of analysts, 'Revenue- Crop Protection- Other' should come in at $213.87 million. The estimate indicates a year-over-year change of +9.1%.
Analysts expect 'Revenue- Seed- Soybean' to come in at $155.13 million. The estimate points to a change of +0.7% from the year-ago quarter.
The consensus among analysts is that 'Revenue- Seed- Corn' will reach $1.41 billion. The estimate indicates a year-over-year change of -0.1%.
The consensus estimate for 'Revenue- Seed- Other' stands at $138.89 million. The estimate points to a change of +15.7% from the year-ago quarter.
It is projected by analysts that the 'Operating EBITDA- Seed' will reach $106.13 million. The estimate compares to the year-ago value of $93.00 million.
The combined assessment of analysts suggests that 'Operating EBITDA- Crop Protection' will likely reach $430.49 million. The estimate compares to the year-ago value of $461.00 million.
Shares of Corteva, Inc. have demonstrated returns of +9% over the past month compared to the Zacks S&P 500 composite's +0.8% change. With a Zacks Rank #1 (Strong Buy), CTVA is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Curious about Corteva, Inc. (CTVA) Q4 Performance? Explore Wall Street Estimates for Key Metrics
The upcoming report from Corteva, Inc. (CTVA - Free Report) is expected to reveal quarterly earnings of $0.21 per share, indicating a decline of 34.4% compared to the year-ago period. Analysts forecast revenues of $4.23 billion, representing an increase of 6.3% year over year.
Over the last 30 days, there has been a downward revision of 3.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.
With that in mind, let's delve into the average projections of some Corteva, Inc. metrics that are commonly tracked and projected by analysts on Wall Street.
Based on the collective assessment of analysts, 'Revenue- Crop Protection' should arrive at $2.42 billion. The estimate indicates a change of +9.8% from the prior-year quarter.
Analysts forecast 'Revenue- Seed' to reach $1.82 billion. The estimate indicates a year-over-year change of +2.6%.
The collective assessment of analysts points to an estimated 'Revenue- Seed- Other oilseeds' of $89.86 million. The estimate indicates a year-over-year change of +3.3%.
Analysts' assessment points toward 'Revenue- Crop Protection- Herbicides' reaching $1.14 billion. The estimate indicates a year-over-year change of +10.9%.
Analysts predict that the 'Revenue- Crop Protection- Insecticides' will reach $557.11 million. The estimate indicates a year-over-year change of +13.7%.
The average prediction of analysts places 'Revenue- Crop Protection- Fungicides' at $357.43 million. The estimate suggests a change of +11.7% year over year.
According to the collective judgment of analysts, 'Revenue- Crop Protection- Other' should come in at $213.87 million. The estimate indicates a year-over-year change of +9.1%.
Analysts expect 'Revenue- Seed- Soybean' to come in at $155.13 million. The estimate points to a change of +0.7% from the year-ago quarter.
The consensus among analysts is that 'Revenue- Seed- Corn' will reach $1.41 billion. The estimate indicates a year-over-year change of -0.1%.
The consensus estimate for 'Revenue- Seed- Other' stands at $138.89 million. The estimate points to a change of +15.7% from the year-ago quarter.
It is projected by analysts that the 'Operating EBITDA- Seed' will reach $106.13 million. The estimate compares to the year-ago value of $93.00 million.
The combined assessment of analysts suggests that 'Operating EBITDA- Crop Protection' will likely reach $430.49 million. The estimate compares to the year-ago value of $461.00 million.
View all Key Company Metrics for Corteva, Inc. here>>>Shares of Corteva, Inc. have demonstrated returns of +9% over the past month compared to the Zacks S&P 500 composite's +0.8% change. With a Zacks Rank #1 (Strong Buy), CTVA is expected to beat the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .